We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




DTI MRI Scans Reveal Brain Differences in Six-Month-Old Autistic Infants

By HospiMedica International staff writers
Posted on 28 Feb 2012
New findings suggest that autism does not appear suddenly in young children, but instead develops over time during infancy. More...
This discovery is significant because it brings scientists one-step closer to developing a biomarker to assist with very early diagnoses for autism spectrum disorders.

A new study from the Infant Brain Imaging Network found significant differences in brain development starting at age six months in high-risk infants who later develop autism, compared to high-risk infants who did not develop autism. “It’s a tremendously exciting finding,” said Sarah Paterson, PhD, director of the Infant neuroimaging lab at the Center for Autism Research at The Children’s Hospital of Philadelphia (CHOP; PA, USA). “We found that the brains of the children who developed autism were markedly different even prior to the onset of behavioral symptoms of autism. Thus, our findings, while requiring replication, are a very important first step towards identifying a biomarker for autism risk. This would enable specialists to diagnose autism much earlier than what is currently possible through behavioral observations.”

The study also suggests that autism does not appear abruptly in young children but instead develops over time during infancy, noted the researchers. Intensive early intervention has been shown to improve outcomes in children with developmental delays and autism. “This research raises the possibility that we might be able to intervene even before a child is six months old, to blunt, or prevent the development of some autism symptoms,” said Dr. Paterson.

The study was published February 17, 2012, in the American Journal of Psychiatry. These findings are the latest from the ongoing Infant Brain Imaging Study (IBIS), which is led at CHOP by Dr. Paterson and Robert Schultz, PhD, who are coauthors on this study.

Participants in the study were 92 infants believed to be at high risk for ASD, because they all have older siblings with autism. Each infant had diffusion tensor imaging (DTI)--a type of magnetic resonance imaging (MRI)--at six months and behavioral assessments at 24 months. Most of the children also had additional brain imaging scans at either or both 12 and 24 months.

At 24 months, 28 infants (30%) met criteria for ASDs while 64 infants (70%) did not. The two groups differed in white matter fiber tract development--pathways that connect brain regions--as measured by fractional anisotropy (FA). FA measures white matter organization and development, based on the movement of water molecules through brain tissue.

This study examined 15 separate fiber tracts, and found considerable differences in FA growth trajectories in 12 of the 15 tracts between infants who did develop autism versus infants who did not. Infants who later developed autism had elevated FA at six months but then experienced slower development over time. By 24 months of age, infants with autism had lower FA values than infants without autism did.

The findings come on the heels of a recent study from London, UK, which found that infants at high risk for autism who were later diagnosed with the condition showed different brain responses from low-risk babies, or from high-risk babies that did not develop autism when shown images of faces looking at or away from the baby. Dr. Paterson reported that the two findings support one another and are promising evidence that scientists are on the right path towards finding markers for identifying autism much earlier than is currently possible.

In addition to the Center for Autism Research at CHOP, other institutions that took part in the study include the University of North Carolina (Chapel Hill, USA), University of Utah (Salt Lake City, USA), Washington University in St. Louis (MO, USA), University of Washington (Seattle, USA), McGill University (Montreal, Canada), and the University of Alberta (Edmonton, Canada).

The Center for Autism Research (CAR) is a collaborative effort between several dozen scientists across multiple departments at the Children’s Hospital of Philadelphia. CAR’s goals are to identify the causes of autism spectrum disorders (ASD) and to use that knowledge to develop more effective treatments. CAR conducts research studies for infants at risk for being diagnosed with ASD (due to having a sibling already diagnosed) as well as toddlers, school-aged children, and adults on the autism spectrum.

Related Links:
Center for Autism Research at The Children’s Hospital of Philadelphia




Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Radiofrequency Generator
GX1
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Masimo smartSET pulse oximetry with PPG AFib and OIRD Detection (Photo courtesy of Masimo)

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Surgical Techniques

view channel
Image: A UTSW clinical trial studied a treatment strategy for kidney cancer with inferior vena cava tumor thrombus (IVC-TT) that used targeted radiation on the tumor thrombus followed by surgery to remove the kidney. (Photo courtesy of UT Southwestern)

Targeted Radiotherapy Before Surgery Improves Control of Kidney Cancer Thrombus

Inferior vena cava tumor thrombus occurs when kidney cancer extends into the body’s largest vein, potentially obstructing blood flow, progressing toward the heart, and making surgery more complex.... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.